Lidocaine Infusion for Pain Relief After Breast Surgery

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Recruiting Phase 3 Interventional Study
Post-mastectomy Pain Syndrome Breast Cancer Pain, Postoperative Pain, Chronic
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
1,602 (estimated)
Sponsor
University Health Network, Toronto · Other
Who this trial is looking for

This trial is looking for adults who are having breast cancer surgery. Participants will receive a medication during surgery to see if it helps reduce pain after their operation.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 18 years old
  • I am scheduled for breast surgery, either a lumpectomy or mastectomy

You may not be able to join if

  • I had breast surgery in the last 6 months
  • I am undergoing a special type of surgery called an autologous flap procedure
  • I have had chronic pain in the area of surgery in the past 3 months
  • I am allergic to lidocaine
  • My surgery is not going to be done under general anesthesia
  • I have a history of serious heart problems without a pacemaker
  • I have cirrhotic liver disease
  • I am pregnant

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥18 years old 2. Undergoing a unilateral or bilateral lumpectomy or mastectomy, inclusive of all pathologies, including prophylactic surgery (e.g., family history or BRCA gene mutation) Exclusion Criteria: 1. Previous breast surgery within 6 months of index surgery 2. U…
Contacts

James Khan

416-340-4800

James.Khan@medportal.ca

CONTACT

Nour Ayach

416-340-4800

Nour.Ayach@uhn.ca

CONTACT